These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25847461)

  • 21. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
    Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic apheresis rescue mission: recurrent focal segmental glomerulosclerosis in renal allografts.
    Keith DS
    Semin Dial; 2012; 25(2):190-2. PubMed ID: 22175233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
    Hickson LJ; Gera M; Amer H; Iqbal CW; Moore TB; Milliner DS; Cosio FG; Larson TS; Stegall MD; Ishitani MB; Gloor JM; Griffin MD
    Transplantation; 2009 Apr; 87(8):1232-9. PubMed ID: 19384172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis.
    Choi KH; Kim SI; Yoon SY; Kim JH; Kang SW; Ha SK; Lee HY; Han DS; Kim YS; Park K; Jeong HJ; Kim DK
    Yonsei Med J; 2001 Apr; 42(2):209-14. PubMed ID: 11371109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide.
    Kershaw DB; Sedman AB; Kelsch RC; Bunchman TE
    Clin Transplant; 1994 Dec; 8(6):546-9. PubMed ID: 7865917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal segmental glomerulosclerosis--does treatment work?
    Stirling CM
    Nephron Clin Pract; 2006; 104(2):c83-4. PubMed ID: 16785739
    [No Abstract]   [Full Text] [Related]  

  • 27. Recurrent focal glomerulosclerosis in renal allografts.
    Garcia V; Abbud-Filho M; Keitel E; Neumann J; Goldani JC
    Transplant Proc; 1995 Feb; 27(1):1084-5. PubMed ID: 7878814
    [No Abstract]   [Full Text] [Related]  

  • 28. Galactose therapy reduces proteinuria in patients with recurrent focal segmental glomerulosclerosis after kidney transplantation.
    Robson K; Hill P; Langsford D; Dwyer K; Goodman D; Langham R
    Nephrology (Carlton); 2015 Mar; 20 Suppl 1():13-6. PubMed ID: 25807852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution of recurrent focal segmental glomerulosclerosis after retransplantation.
    Gallon L; Leventhal J; Skaro A; Kanwar Y; Alvarado A
    N Engl J Med; 2012 Apr; 366(17):1648-9. PubMed ID: 22533598
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation.
    Fujisawa M; Iijima K; Ishimura T; Higuchi A; Isotani S; Yoshiya K; Arakawa S; Hamami G; Matsumoto O; Yoshikawa N; Kamidono S
    Pediatr Nephrol; 2002 Mar; 17(3):165-8. PubMed ID: 11956852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
    Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
    Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL
    Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of recurrent focal segmental glomerulosclerosis combined with calcineurin inhibitor nephrotoxicity four yr after kidney transplantation.
    Mitome J; Yamamoto H; Maruyama Y; Kobayashi A; Yaginuma T; Matsuo N; Tanno Y; Hayakawa H; Miyazaki Y; Yokoyama K; Utsunomiya Y; Yamaguchi Y; Hosoya T
    Clin Transplant; 2010 Jul; 24 Suppl 22():48-53. PubMed ID: 20590695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation.
    Gonzalez E; Ettenger R; Rianthavorn P; Tsai E; Malekzadeh M
    Pediatr Transplant; 2011 Aug; 15(5):495-501. PubMed ID: 21338460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of renal transplantation in focal glomerulosclerosis.
    Akioka K; Okamoto M; Wakabayashi Y; Nobori S; Ogino S; Ushigome H; Uryuhara K; Kaihara S; Yoshimura N
    Transplant Proc; 2006 Nov; 38(9):2819-22. PubMed ID: 17112838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotic focal segmental glomerulosclerosis in 2004: an update.
    Meyrier A
    Nephrol Dial Transplant; 2004 Oct; 19(10):2437-44. PubMed ID: 15280528
    [No Abstract]   [Full Text] [Related]  

  • 38. Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation.
    Apeland T; Hartmann A
    Nephrol Dial Transplant; 2008 Jun; 23(6):2091-4. PubMed ID: 18319357
    [No Abstract]   [Full Text] [Related]  

  • 39. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.
    Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P
    Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
    Goumenos DS; Tsagalis G; El Nahas AM; Shortland JR; Davlouros P; Vlachojannis JG; Brown CB
    Nephron Clin Pract; 2006; 104(2):c75-82. PubMed ID: 16785738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.